Please note that a very interesting Quality Improvement RFP has been added to the current funding opportunities listing with an application cut-off of 6 Oct … apologies for the late posting! Dear All, First up, CARB-X has at long last announced new funding rounds! As you’ll recall, CARB-X was recently funded for another 10 years by BARDA and Wellcome
Dear All, I have many times previously shared webinars from the excellent policy team at Duke-Margolis Center for Health Policy. Excitingly if you are in search of that type of role, they are now looking for a Policy Analyst who would be located in either Washington, DC or Durham, NC. Here is the verbatim job summary from
Dear All, Ahead of World Antimicrobial Awareness Week, I sat down with AMR Action Fund Chief Investment Officer Martin Heidecker for a Fireside Chat. It was a fabulous conversation that covered everything from how the Fund’s investment process works to what it’s looking for in portfolio companies to broader investment trends in the AMR space. As
Dear All, Wellcome Trust has renewed their support of AMR.Solutions and, with that, I’d like to share with you a survey about this newsletter. There are 3 questions and an optional comment box for you to write any additional thoughts you may have about this newsletter. I personally found last year’s survey to be highly
Dear All, I wrote on 3 Jan 2020 (link) about the NIAID contract intended to establish an innovative Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB). The formal solicitation has now gone live and can be found here. The deadline for applications is 16 Mar 2020. Get to it! In parallel, there is a superb Wall Street Journal podcast dated 13 Jan 2020 about
Dear All, I was fascinated to see Mayo Clinic’s Global Bridges Healthcare Alliance release an RFP on 21 Oct entitled “Antimicrobial Stewardship (AMS) Programs to Address Health Inequities arising from Socioeconomic Disparities in USA, Europe, Japan, South Korea, Australia and New Zealand.” The RFP is supported by a grant from Pfizer and seeks to “… solicit programs that have
Dear All, And now for something really different! With the recent GRAM report (20 Jan 2022 newsletter) showing that AMR is linked to more deaths that HIV or malaria (#AMRSOS! Andrew Jack and FT team have some great graphics for this … check them out!), we now have an absolutely fascinating call from Wellcome Trust for
Dear All: I wrote a few weeks ago about the Stopping Superbugs series from PBS Newshour. PBS has since then added some superb new materials: A marvelous 10-minute video story on agricultural use of antibiotics A column on Maryn McKenna’s upcoming Big Chicken book (scheduled for release on 12 Sep) A column on the never-ending debate about taking the entire course of antibiotics These build on
Dear All: Frontline will today broadcast an updated version of the excellent Hunting the Nightmare Bacteria show that first broadcast in 2013. Here’s the link to the announcement and here is the short description of this 1-h program: “Described by the Centers for Disease Control and Prevention as “nightmare bacteria,” there are now predictions that drug-resistant superbugs will kill more
Dear All, World Antimicrobial Awareness Week (WAAW) was such a mad scramble! So many events … just no way to attend everything. Some of the highlights in and around WAAW (not everything was precisely within the WAAW dates, thank goodness!) for me were: Andrew Jack and the team at FT (Financial Times) have released an
